Tempus ECG-AF vs Vista OS
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify older patients (65+) at an elevated risk of developing new-onset atrial fibrillation within the next year, utilizing existing 12-lead ECG data. This tool is ideal for integrating into routine geriatric care or internal medicine practices to enable earlier intervention and follow-up before symptomatic AF manifests.
View Tempus ECG-AF →Choose Vista OS if…
Choose Vista OS if your objective is to enhance the efficiency, consistency, and quality of cardiac MRI acquisitions within your radiology or cardiology department. This AI-powered solution is best suited for facilities looking to automate scan planning, optimize image parameters, and improve workflow to increase patient access and throughput for cardiac MRI studies.
View Vista OS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Vista OS |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Vista AI Scan installs on customer-provided hardware and communicates directly with GE and Siemens MRI scanners. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Vista OSTool B (Vista OS) emphasizes an 'AI-driven toolkit for technologists' and 'automated scan planning & localization in 30 seconds,' directly simplifying and speeding up complex cardiac MRI acquisition. While Tool A integrates with existing ECG systems, Tool B's focus on automating a highly technical procedure offers a more significant improvement in user workflow and efficiency for technologists.
Clinical Value
Tempus ECG-AFTool A (Tempus ECG-AF) directly aids in early disease detection by identifying patients at increased risk of developing atrial fibrillation within 12 months, potentially leading to earlier intervention and improved patient outcomes. Tool B focuses on enhancing the acquisition of high-quality cardiac MRI, which is valuable but an indirect contribution to clinical outcomes compared to direct risk identification.
Pricing & Value
Tempus ECG-AFTool A (Tempus ECG-AF) provides clear financial benefits with explicit CMS reimbursement availability and a specific Medicare rate of $128.90, effective January 1, 2025. Tool B's pricing is not publicly disclosed, making it impossible to assess its value proposition or financial benefits for healthcare providers.
Enterprise Readiness
Tempus ECG-AFBoth tools are FDA-cleared and integrate with existing systems. However, Tool A (Tempus ECG-AF) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical assurances for enterprise deployment. Tool B's HIPAA compliance and BAA are only stated as 'likely' or 'highly probable,' offering less explicit confirmation for enterprise-level adoption.
Innovation
Vista OSWhile both leverage AI, Tool B (Vista OS) demonstrates a more innovative application by automating and optimizing the complex, multi-step process of cardiac MRI acquisition, including real-time motion detection and rapid scan planning. This fundamentally changes a highly skilled workflow. Tool A's use of AI for predictive risk assessment from ECGs is also innovative, but Tool B's automation of a complex imaging procedure represents a significant leap in operational efficiency and consistency.
Support & Docs
Tempus ECG-AFTempus ECG-AF explicitly provides dedicated contact information for technical support, including an email address and phone number, indicating a clear and accessible support channel for users. In contrast, public information for Vista OS does not detail specific product support or documentation resources beyond general company contact information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Vista OS |
|---|---|---|
| Product Name | Tempus ECG-AF | Vista OS |
| Primary Function | AI-based algorithm analyzing 12-lead ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. | AI-powered software that automates and simplifies cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging. |
| Intended Use/Target | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, for early identification and follow-up of new onset AF within 12 months. | Automated cardiac MRI acquisition, scan planning, localization, parameter tuning, real-time motion & artifact detection, and in-line analysis for technologists. |
| System Compatibility | FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. | GE or Siemens MRI systems; integration with common PACS and post-processing software. |
| Clinical Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Vista OS.